PD 0332991

palbociclib

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PD 0332991, covering 2021-03-11 to 2021-06-11. Get the full timeline:

Most recent: Clinical Trial Update: PD 0332991 and Cetuximab in Patients With Incurable SCCHN [Phase 1, Phase 2]